196 related articles for article (PubMed ID: 22920203)
21. Synchronous congenital malignant rhabdoid tumor of the orbit and atypical teratoid/rhabdoid tumor--feasibility and efficacy of multimodal therapy in a long-term survivor.
Seeringer A; Reinhard H; Hasselblatt M; Schneppenheim R; Siebert R; Bartelheim K; Leuschner I; Frühwald MC
Cancer Genet; 2014 Sep; 207(9):429-33. PubMed ID: 25262118
[TBL] [Abstract][Full Text] [Related]
22. Biology and Treatment of Rhabdoid Tumor.
Geller JI; Roth JJ; Biegel JA
Crit Rev Oncog; 2015; 20(3-4):199-216. PubMed ID: 26349416
[TBL] [Abstract][Full Text] [Related]
23. Clinical and genetic features of rhabdoid tumors of the heart registered with the European Rhabdoid Registry (EU-RHAB).
Bartelheim K; Sumerauer D; Behrends U; Kodetova D; Kucera F; Leuschner I; Neumayer P; Oyen F; Rübe C; Siebert R; Schneppenheim R; Seeringer A; Vasovcak P; Frühwald MC
Cancer Genet; 2014 Sep; 207(9):379-83. PubMed ID: 24972932
[TBL] [Abstract][Full Text] [Related]
24. Rhabdoid tumor of the kidney is a component of the rhabdoid predisposition syndrome.
Lee HY; Yoon CS; Sevenet N; Rajalingam V; Delattre O; Walford NQ
Pediatr Dev Pathol; 2002; 5(4):395-9. PubMed ID: 12016529
[TBL] [Abstract][Full Text] [Related]
25. High-resolution genomic analysis suggests the absence of recurrent genomic alterations other than SMARCB1 aberrations in atypical teratoid/rhabdoid tumors.
Hasselblatt M; Isken S; Linge A; Eikmeier K; Jeibmann A; Oyen F; Nagel I; Richter J; Bartelheim K; Kordes U; Schneppenheim R; Frühwald M; Siebert R; Paulus W
Genes Chromosomes Cancer; 2013 Feb; 52(2):185-90. PubMed ID: 23074045
[TBL] [Abstract][Full Text] [Related]
26. Frequent overexpression of HMGA2 in human atypical teratoid/rhabdoid tumor and its correlation with let-7a3/let-7b miRNA.
Zhang K; Gao H; Wu X; Wang J; Zhou W; Sun G; Wang J; Wang Y; Mu B; Kim C; Chu P; Ho DM; Ann DK; Wong TT; Yen Y
Clin Cancer Res; 2014 Mar; 20(5):1179-89. PubMed ID: 24423609
[TBL] [Abstract][Full Text] [Related]
27. Atypical teratoid/rhabdoid tumor arising in a ganglioglioma: genetic characterization.
Kleinschmidt-DeMasters BK; Birks DK; Aisner DL; Hankinson TC; Rosenblum MK
Am J Surg Pathol; 2011 Dec; 35(12):1894-901. PubMed ID: 22082607
[TBL] [Abstract][Full Text] [Related]
28. Rhabdoid tumors: integrating biological insights with clinical success: a report from the SMARCB1 and Rhabdoid Tumor Symposium, Paris, December 12-14, 2013.
Bourdeaut F; Chi SN; Frühwald MC
Cancer Genet; 2014 Sep; 207(9):346-51. PubMed ID: 25468731
[TBL] [Abstract][Full Text] [Related]
29. Atypical teratoid/rhabdoid tumor of the pineal region in an adult.
Takei H; Adesina AM; Mehta V; Powell SZ; Langford LA
J Neurosurg; 2010 Aug; 113(2):374-9. PubMed ID: 19911885
[TBL] [Abstract][Full Text] [Related]
30. Spectrum of SMARCB1/INI1 mutations in familial and sporadic rhabdoid tumors.
Eaton KW; Tooke LS; Wainwright LM; Judkins AR; Biegel JA
Pediatr Blood Cancer; 2011 Jan; 56(1):7-15. PubMed ID: 21108436
[TBL] [Abstract][Full Text] [Related]
31. No small surprise - small cell carcinoma of the ovary, hypercalcaemic type, is a malignant rhabdoid tumour.
Foulkes WD; Clarke BA; Hasselblatt M; Majewski J; Albrecht S; McCluggage WG
J Pathol; 2014 Jul; 233(3):209-14. PubMed ID: 24752781
[TBL] [Abstract][Full Text] [Related]
32. Premature termination of SMARCB1 translation may be followed by reinitiation in schwannomatosis-associated schwannomas, but results in absence of SMARCB1 expression in rhabdoid tumors.
Hulsebos TJ; Kenter S; Verhagen WI; Baas F; Flucke U; Wesseling P
Acta Neuropathol; 2014 Sep; 128(3):439-48. PubMed ID: 24740647
[TBL] [Abstract][Full Text] [Related]
33. Molecular genetics of atypical teratoid/rhabdoid tumor.
Biegel JA
Neurosurg Focus; 2006 Jan; 20(1):E11. PubMed ID: 16459991
[TBL] [Abstract][Full Text] [Related]
34. Non-rhabdoid pediatric SMARCB1-deficient tumors: overlap between chordomas and malignant rhabdoid tumors?
Renard C; Pissaloux D; Decouvelaere AV; Bourdeaut F; Ranchère D
Cancer Genet; 2014 Sep; 207(9):384-9. PubMed ID: 25053104
[TBL] [Abstract][Full Text] [Related]
35. Alterations of the hSNF5/INI1 gene in central nervous system atypical teratoid/rhabdoid tumors and renal and extrarenal rhabdoid tumors.
Biegel JA; Tan L; Zhang F; Wainwright L; Russo P; Rorke LB
Clin Cancer Res; 2002 Nov; 8(11):3461-7. PubMed ID: 12429635
[TBL] [Abstract][Full Text] [Related]
36. Rhabdoid tumors: clinical approaches and molecular targets for innovative therapy.
Kerl K; Holsten T; Frühwald MC
Pediatr Hematol Oncol; 2013 Oct; 30(7):587-604. PubMed ID: 23848359
[TBL] [Abstract][Full Text] [Related]
37. A novel mutation of the SMARCB1 gene in a case of extrarenal malignant rhabdoid tumor.
Koitabashi M; Kanazawa T; Tamura K; Tsukada S; Suzuki M; Morikawa A; Ogawa C; Hirado J
Cancer Genet Cytogenet; 2008 Feb; 181(1):67-8. PubMed ID: 18262058
[No Abstract] [Full Text] [Related]
38. ERG and SALL4 expressions in SMARCB1/INI1-deficient tumors: a useful tool for distinguishing epithelioid sarcoma from malignant rhabdoid tumor.
Kohashi K; Yamada Y; Hotokebuchi Y; Yamamoto H; Taguchi T; Iwamoto Y; Oda Y
Hum Pathol; 2015 Feb; 46(2):225-30. PubMed ID: 25479928
[TBL] [Abstract][Full Text] [Related]
39. Germ-line and acquired mutations of INI1 in atypical teratoid and rhabdoid tumors.
Biegel JA; Zhou JY; Rorke LB; Stenstrom C; Wainwright LM; Fogelgren B
Cancer Res; 1999 Jan; 59(1):74-9. PubMed ID: 9892189
[TBL] [Abstract][Full Text] [Related]
40. Cancer Surveillance in Gorlin Syndrome and Rhabdoid Tumor Predisposition Syndrome.
Foulkes WD; Kamihara J; Evans DGR; Brugières L; Bourdeaut F; Molenaar JJ; Walsh MF; Brodeur GM; Diller L
Clin Cancer Res; 2017 Jun; 23(12):e62-e67. PubMed ID: 28620006
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]